These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 38589763)

  • 1. Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts.
    Diakite I; Martins B; Owusu-Edusei K; Palmer C; Patterson-Lomba O; Gomez-Lievano A; Zion A; Simpson R; Daniels V; Elbasha E
    Infect Dis Ther; 2024 May; 13(5):965-990. PubMed ID: 38589763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost effectiveness of a quadrivalent human papillomavirus vaccine (6/11/16/18) in Hungary.
    Dasbach EJ; Nagy L; Brandtmüller A; Elbasha EH
    J Med Econ; 2010 Mar; 13(1):110-8. PubMed ID: 20085477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases.
    Diakite I; Nguyen S; Sabale U; Pavelyev A; Saxena K; Tajik AA; Wang W; Palmer C
    J Med Econ; 2023; 26(1):1085-1098. PubMed ID: 37608730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human papillomavirus vaccine as a treatment for human papillomavirus-related dysplastic and neoplastic conditions: A literature review.
    Pham CT; Juhasz M; Sung CT; Mesinkovska NA
    J Am Acad Dermatol; 2020 Jan; 82(1):202-212. PubMed ID: 31085272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.
    Insinga RP; Dasbach EJ; Elbasha EH
    BMC Infect Dis; 2009 Jul; 9():119. PubMed ID: 19640281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
    Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M
    Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe.
    Hartwig S; St Guily JL; Dominiak-Felden G; Alemany L; de Sanjosé S
    Infect Agent Cancer; 2017; 12():19. PubMed ID: 28400857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
    Préaud E; Largeron N
    J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.
    Insinga RP; Dasbach EJ; Elbasha EH
    Pharmacoeconomics; 2005; 23(11):1107-22. PubMed ID: 16277547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan.
    Yamabe K; Singhal PK; Abe M; Dasbach EJ; Elbasha EH
    Value Health Reg Issues; 2013 May; 2(1):92-97. PubMed ID: 29702859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updating the natural history of human papillomavirus and anogenital cancers.
    Moscicki AB; Schiffman M; Burchell A; Albero G; Giuliano AR; Goodman MT; Kjaer SK; Palefsky J
    Vaccine; 2012 Nov; 30 Suppl 5(0 5):F24-33. PubMed ID: 23199964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis.
    Kechagias KS; Kalliala I; Bowden SJ; Athanasiou A; Paraskevaidi M; Paraskevaidis E; Dillner J; Nieminen P; Strander B; Sasieni P; Veroniki AA; Kyrgiou M
    BMJ; 2022 Aug; 378():e070135. PubMed ID: 35922074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
    ; Dillner J; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Maansson R; Lu S; Vuocolo S; Hesley TM; Barr E; Haupt R
    BMJ; 2010 Jul; 341():c3493. PubMed ID: 20647284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What should be known for the introduction of an HPV vaccine?].
    Muñoz N; Jacquard AC
    Presse Med; 2008 Oct; 37(10):1377-90. PubMed ID: 18786806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.
    Haeussler K; Marcellusi A; Mennini FS; Favato G; Picardo M; Garganese G; Bononi M; Costa S; Scambia G; Zweifel P; Capone A; Baio G
    Value Health; 2015 Dec; 18(8):956-68. PubMed ID: 26686779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and Resource Use Among Patients with Cervical Cancer, Cervical Intraepithelial Neoplasia, and Genital Warts in Algeria.
    Bennacef AC; Khodja AA; Abou-Bekr FA; Ndao T; Holl R; Benčina G
    J Health Econ Outcomes Res; 2022; 9(1):31-38. PubMed ID: 35224126
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.
    Wolf J; Kist LF; Pereira SB; Quessada MA; Petek H; Pille A; Maccari JG; Mutlaq MP; Nasi LA
    Rev Med Virol; 2024 May; 34(3):e2537. PubMed ID: 38666757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors.
    Damm O; Nocon M; Roll S; Vauth C; Willich S; Greiner W
    GMS Health Technol Assess; 2009 Mar; 5():Doc04. PubMed ID: 21289891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.